fontanpalliation.Heart.2006;92:1290–1294.
46.GoutonM,NizardJ,PatelM,etal.Maternaland
fetaloutcomesofpregnancywithfontan
circulation:amulticentricobservationalstudy.
IntJCardiol.2015;187:84–89.
47.PundiKN,PundiK,JohnsonJN,etal.
Contraceptionpracticesandpregnancyoutcome
inpatientsafterfontanoperation.Congenit
HeartDis.2016;11:63–70.
48.PresbiteroP,SomervilleJ,StoneS,etal.
Pregnancyincyanoticcongenitalheartdisease.
Outcomeofmotherandfetus.Circulation.
1994;89:2673–2676.
49.LadouceurM,BenoitL,BasquinA,etal.How
pregnancyimpactsadultcyanoticcongenital
heartdisease:Amulticenterobservationalstudy.
Circulation.2017;135:2444–2447.
50.ConnollyHM,WarnesCA.Outcomeof
pregnancyinpatientswithcomplexpulmonic
valveatresia.AmJCardiol.1997;79:519–521.
51.NeumayerU,SomervilleJ.Outcomeof
pregnanciesinpatientswithcomplexpulmonary
atresia.Heart.1997;78:16–21.
52.BedardE,DimopoulosK,GatzoulisMA.Has
therebeenanyprogressmadeonpregnancy
outcomesamongwomenwithpulmonary
arterialhypertension?EurHeartJ.
2009;30:256–265.
53.KielyDG,CondliffeR,WebsterV,etal.
Improvedsurvivalinpregnancyandpulmonary
hypertensionusingamultiprofessional
approach.BJOG.2010;117:565–574.
54.LadouceurM,BenoitL,RadojevicJ,etal.
Pregnancyoutcomesinpatientswithpulmonary
arterialhypertensionassociatedwithcongenital
heartdisease.Heart.2017;103:287–292.
55.WangaS,SilversidesC,DoreA,deWaardV,
MulderB.Pregnancyandthoracicaortic
disease:managingtherisks.CanJCardiol.
2016;32:78–85.
56.RossiterJP,RepkeJT,MoralesAJ,MurphyEA,
PyeritzRE.Aprospectivelongitudinal
evaluationofpregnancyinthemarfan
syndrome.AmJObstetGynecol.
1995;173:1599–1606.
57.DonnellyRT,PintoNM,KocolasI,YetmanAT.
Theimmediateandlong-termimpactof
pregnancyonaorticgrowthrateandmortalityin
womenwithmarfansyndrome.JAmColl
Cardiol.2012;60:224–229.
58.BaddukeBR,JamiesonWR,MiyagishimaRT,et
al.Pregnancyandchildbearinginapopulation
withbiologicvalvularprostheses.JThorac
CardiovascSurg.1991;102:179–186.
59.JamiesonWR,MillerDC,AkinsCW,etal.
Pregnancyandbioprostheses:influenceon
structuralvalvedeterioration.AnnThoracSurg.
1995;60:S282–S286[discussionS287].
60.NorthRA,SadlerL,StewartAW,etal.Longtermsurvivalandvalve-relatedcomplicationsin
youngwomenwithcardiacvalvereplacements.
Circulation.1999;99:2669–2676.
61.DoreA,SomervilleJ.Pregnancyinpatientswith
pulmonaryautograftvalvereplacement.Eur
HeartJ.1997;18:1659–1662.
62.YapSC,DrenthenW,PieperPG,etal.Outcome
ofpregnancyinwomenafterpulmonary
autograftvalvereplacementforcongenitalaortic
valvedisease.JHeartValveDis.2007;16:398–
403.
63.D'SouzaR,OstroJ,ShahPS,etal.
Anticoagulationforpregnantwomenwith
mechanicalheartvalves:asystematicreview
andmeta-analysis.EurHeartJ.2017;38:1509–
1516.
64.SteinbergZL,Dominguez-IslasCP,OttoCM,
StoutKK,KriegerEV.Maternalandfetal
outcomesofanticoagulationinpregnantwomen
withmechanicalheartvalves.JAmColl
Cardiol.2017;69:2681–2691.
65.VitaleN,DeFeoM,DeSantoLS,etal.Dose-